Beyond Time in Range: Targeting Glucose Oscillations to Transform Vascular Outcomes in Diabetes.

BACKGROUND

Time in range (TIR) is now widely adopted as a metric in diabetes management, offering a dynamic improvement over HbA1c alone. However, TIR does not capture the clinically relevant burden of glucose oscillations-rhythmic, intrarange fluctuations that independently drive oxidative stress, endothelial dysfunction, and inflammation, even when mean glucose remains well-controlled.

OBJECTIVE

We propose oscillatory burden as a measurable, actionable dimension of glycemic risk. This review synthesizes mechanistic and clinical evidence linking oscillations to vascular complications and outlines a conceptual oscillatory burden index (OBI) that combines amplitude and frequency metrics using continuous glucose monitoring (CGM) data.

METHODS

We reviewed studies published from 2002 to 2024 examining postprandial and intraday glucose dynamics, oxidative and inflammatory biomarkers, endothelial dysfunction, and real-world CGM applications.

RESULTS

Intermittent glucose swings increase mitochondrial ROS generation, activate NF-κB, and impair nitric oxide availability-mechanisms confirmed by translational studies. Patients with comparable TIR (70-80%) but high oscillatory burden showed 2-3 times higher CRP and ICAM-1 levels compared to low-burden peers (p < 0.05). Practical strategies-precision meal timing, low-GI diets, gut microbiota modulation, and advanced CGM-driven insulin titration-can reduce oscillatory burden by up to 30%.

CONCLUSION

Achieving TIR must not mask hidden glucose instability. Integrating oscillatory metrics into routine practice, supported by modern CGM analytics and patient-specific coaching, offers a new frontier for protecting vascular health in diabetes.